How to protect environment and employees against cytotoxic agents,the UZ Ghent experience

Abstract

Objective. To compare two different systems for the reconstitution and preparation of cytotoxic drug-containing infusion bags. The Classical System (open) uses Luer lock syringes and needles, and the PhaSeal^A System (closed) uses special devices.

Methods. Both wipe samples of the Biological Safety Cabinet (BSC) plus surroundings and urine analysis of technicians and pharmacists involved in the preparatory activities were used. Analyses were performed using gas chromatography in tandem with mass spectroscopy.

Results. An important difference has been found in the surface contamination rate and in the number, periods and values of contaminated urine samples in favour of the closed PhaSeal^A System. J Oncol Pharm Practice (2001) 6, 146-152.

Keywords

Cytotoxic drugs contamination cyclophosphamide pharmacy toxicity health risk environmental wipe samples urine samples cytotoxic contamination monitoring safe handling

Get full access to this article

View all access options for this article.

References

Valanis B , Vollmer W , Labuhn K , Glass A. Association of antineoplastic drug handling with acute adverse effects in pharmacy personnel. Am J Hosp Pharm. 1993;50: 455-462.

Kaijser GP , Underberg WJM , Beijnen JH. The risk of handling cytotoxic drugs. Pharm Weekbl, Sci Ed. 1990;12:217-235.

Power LA , Anderson RW , Cortopassi R , Gera JR , Lewis RM Jr. Update on safe handling of hazardous drugs: the advise of experts. Am J Hosp Pharm. 1990;47:1050-1060.

Hemminki K , Kyyrönen P , Lindbohm ML. Spontaneous abortions and malformations in the offspring of nurses exposed to anaesthetic gases, cytostatic drugs and other potential hazards in hospitals, based on registered information of outcome. J Epidemiol Community Health. 1985;39:141-147.

Gabriele P , Airoldi M , Succo G , Brando V , Grazia Ruo Redda M. Undifferentiated nasopharyngeal-type carcinoma in a nurse handling cytostatic agents. Eur J Cancer. 1993;29B:153-153.

Peelen S , Roeleveld N , Heederik D , Krombout H , Kort W. Toxic effects on reproduction in hospital personnel. Dutch Minist Soc Aff Employ. 1999. ISBN 90 5749 255 5 (in Dutch).

Stücker I , Caillard JF , Collin R , Gout M , Poyen D , He`non D. Risk of spontaneous abortion among nurses handling antineoplastic drugs. Scand J Work Environ Health. 1990;16:102-107.

Hansen J , Olsen JH. Cancer morbidity among Danish female pharmacy technicians. Scand J Work Environ Health. 1994;20:22-26.

Sessink PJM , Kroese ED , Van Kranen HJ , Bos RP. Cancer risk assessment for health care workers occupationally exposed to cyclophosphamide. Int Arch Occup Environ Health. 1995;67:317-323.

10.

Opiolka. Besteht ein ausreichender Personenschutz bei der Zytostatika-zubereitung? Krankenhaus Technik, 03/1998.

11.

Opiolka. Grenzen des Personenschutzes beim Einsatz von Sicherheitswerkbänken. Mitteilungen aus dem Institut für Umwelttechnologie und Umweltanalytic (IUTA), 1998.

12.

Sessink PJM , Cerna`M , Rössner P , Pastorkova A , et al. Urinary cyclophosphamide excretion and chromosomal abberations in peripheral blood lymphocytes after occupational exposure to antineoplastic agents. Mutat Res. 1994;309:193-199.

13.

Sessink PJM , Frieme`l NSS , Anzion RBM , Bos RP. Biological and environmental monitoring of occupational exposure of pharmaceutical plant workers to methotrexate. Int Arch Occup Environ Health. 1994; 65:401-403.

14.

Sessink PJM , Joost HC , Pierik FH , Anzion RBM , Bos RP. Occupational exposure of animal caretakers to cyclophosphamide. J Occup Med. 1993;35:47-52.

15.

Sessink PJM , Boer KA , Scheefhaals APH , Anzion RBM , Bos RP. Occupational exposure to antineoplastic agents at several departments in a hospital: Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers. Int Arch Occup Environ Health. 1992;64:105-112.

16.

Sessink PJM , Timmermans JL , Anzion RBM , Bos RP. Assessment of occupational exposure of pharmaceutical plant workers to 5-fluorouracil. J Occup Med. 1994;36:79-83.

17.

Sessink PJM , Van de Kerkhof MCA , Noordhoek J , Anzion RBM , Bos RP. Environmental contamination and assessment of exposure to antineoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: Is skin absorption an important route? Arch Environ Health. 1994;49:165-169.

18.

Sessink PJM , Wittenhorst BCJ , Anzion RBM , Rob RP. Exposure of pharmacy technicians to antineo-plastic agents: Reevaluation after additional protective measures. Arch Environ Health. 1997;52:240-244.

19.

Sessink PJM , Anzion RBM , Van den Broek PHH , Rob RP. Detection of contamination with antineoplastic agents in a hospital pharmacy department. Pharm Weekbl, Sci Ed. 1992;64:16-22.

20.

Bos RP , Sessink PJM. Biomonitoring of occupational exposure to cytostatic anticancer drugs. Rev Environ Health. 1997;12:43-58.

21.

Sessink PJM , Kroese ED , Van Kranen HJ , Bos RP. Cancer risk assessment for health care workers occupationally exposed to cyclophosphamide. Int Arch Occup Environ Health. 1995;67:317-323.

22.

Connor TH , Anderson RW , Sessink PJM , Broadfield L , Power LA. Surface contamination with antineo-plastic agents in six cancer treatment centers in the United States and Canada. Am J Health-Syst Pharm. 1999;56:1427-1432.

23.

Sessink PMJ , Rolf M , Ryde`n NS. Evaluation of the PhasealA Hazardous Drugs Containment System. Hosp Pharm. 1999.